End of collaboration Oncomfort & Mario Huyghe Mario – 2022-05-31
Oncomfort and Mario Huyghe mutually agreed to terminate the collaboration based on differences in view on the company’s strategy implementation. Under the leadership of Mario, the Company has introduced Digital Sedation™ and a strong pipeline of innovations that entail the potential to make quantified Digital Sedation™ a true clinical breakthrough. We also introduced structures and processes of a real medical device company and strengthened the company with its own development team. We thank Mario, who remains a shareholder, for his dedication and leadership to bring Oncomfort to this stage with market-ready products and look forward to accelerating the global deployment taking it to the next level. While appointing a new CEO, the Chairman of the Board of Directors and the Chief Scientific Officer shall ensure a smooth continuation of the business.